Abstract
Background
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by defective social communication and interaction with a repetitive pattern of monotonous or stereotyped behavior. Although the exact etiology of ASD is unknown, many factors may be implicated in the development of ASD. We aimed to determine the correlation between specific parental factors and Autism Treatment Evaluation Checklist (ATEC) scores.
Methods
This cross-sectional study was conducted at the Prince Nasser Bin Abdulaziz Center for Autism, Autism Center for Excellence, and Academy of Special Education for Autism in Riyadh, Saudi Arabia. We enrolled children diagnosed with ASD and their parents from these centers. Data were collected through self-administered questionnaires to the patients’ parents.
Results
All included children were <18 years old. In total, 71 (92.2%) children were male and six (7.8%) were female. Further, 77 (100%) patients were diagnosed with autistic disorder. Children of consanguineous parents, underweight mothers and obese fathers, mothers with a history of depression during pregnancy, and mothers aged ≥31 years during pregnancy tend to have a higher mean ATEC score. The health domain was the most significantly correlated with ATEC scores, with a Pearson correlation of 0.880. In linear regression analysis, only maternal depression during pregnancy was significantly correlated with ATEC scores.
Conclusion
Our patients had a mean ATEC score of 86.2. The health domain was the most significantly correlated with ATEC scores, with a Pearson correlation of 0.880. Linear regression analysis revealed that consanguinity, parental chronic disease, parental allergy, smoking, drug use during pregnancy, paternal and maternal body mass index (BMI), and sibling number were not significantly correlated with ATEC scores (P=0.701, 0.693, 0.133, 0.874, 0.982, 0.255, 0.778, and 0.502, respectively). However, maternal depression during pregnancy was significantly correlated with ATEC scores (P=0.055).
Keywords: autism severity, autism spectrum disorder (asd), autism treatment evaluation checklist, parental comorbidities, autism
Introduction
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by a serious loss of communication and socialization with a pattern of monotonous or stereotyped behavior. According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), ASD can be categorized as pervasive development disorder, autistic disorder, Asperger’s syndrome, childhood disintegrative disorder, and Rett’s syndrome. Approximately 1% of the population is affected by ASD [1]. In Saudi Arabia, 42,500 confirmed cases of ASD [2] were reported in 2002, a number dramatically higher than that reported worldwide. Since the 1960s, the prevalence of ASD and higher body mass index (BMI) has been dramatically increasing. Thus far, ASD has not been sufficiently studied, and its comorbidities and pathogenesis are unclear.
Some studies have shown that individuals with ASD have the same comorbidities as those with normal neurodevelopment, but their presentation may differ [3]. Furthermore, some studies have shown that some characteristics of ASD may impede the diagnosis of neuropsychiatric comorbid conditions by physicians used to diagnosing disorders with usual presentation and symptoms in normal society [4,5]. Individuals with impairment in social interactions and deficits in speech in addition to ASD are generally unable to explain their issue appropriately and, therefore, unable to explain their physical symptoms adequately. Furthermore, individuals with impairments in sensory processing and ASD may face issues in reporting the location of the pain or any discomfort due to an underlying medical issue [6], which may lead to suboptimal patient care or delayed medical care.
Moreover, it is important to consider the nutritional condition of the parents and their affected offspring. The proportion of child-bearing women is more than one-third of the population [7]. Among them, 9% have prepregnancy diabetes and pregestational diabetes, and an additional 2%-9% develop gestational diabetes during pregnancy [8]. In addition, evidence has shown a correlation between maternal and paternal diabetes and a higher incidence of ASD in children [9]. All subtypes of ASD are weakly associated with maternal obesity, and ASD is associated with increased paternal weight as children of overweight fathers are at risk of developing Asperger’s disorder and ASD [10].
Based on the aforementioned facts and considerations, there is a lack of knowledge on ASD in general and, specifically, on the association between parental comorbidities and ASD severity in children. Hence, we aimed to evaluate the association between these comorbidities and ASD severity.
Materials and methods
Study design and setting
This cross-sectional study was conducted at Prince Nasser Bin Abdulaziz Center for Autism, Autism Center for Excellence, and Academy of Special Education for Autism in Riyadh, Saudi Arabia. We included children diagnosed with ASD and their parents from these centers. We included all patients with a confirmed ASD according to the DSM-5 criteria and excluded all patients aged >18 years.
Data collection
We collected data through separate self-administered questionnaires on patient demographics, premorbid conditions, and Autism Treatment Evaluation Checklist (ATEC) scores for each domain. Data on parents’ demographics, premorbid conditions, familial contiguity, smoking status, and drug use during pregnancy were also collected. Furthermore, data on siblings with chronic diseases and ASD were collected. We included all patients with a confirmed diagnosis of any of the five types of ASD according to the DSM-5 criteria and excluded all patients aged >18 years. Assuming the prevalence of specific comorbidities in children diagnosed with ASD of 50% and using the Raosoft calculator (Raosoft, Inc., Seattle, WA, USA) set at a 95% confidence interval and 5% margin of error, the sample size was determined to be 369 patients, but we only obtained data from 77 patients and their parents. Informed consent was obtained from the study participants’ guardians prior to study commencement.
Data were collected using the ATEC to measure the association. This tool assesses four domains: speech, consisting of 14 questions; sociability, consisting of 20 questions; cognitive and sensory, consisting of 18 questions; and physical and behavioral health, consisting of 25 questions. A validated Arabic version of the ATEC was used in this study.
The ATEC was developed by Rimland and Edelson [11]. It is easy to use, translate, and complete. This self-administered questionnaire consists of a one-page checklist that is administered to patients’ parents. The ATEC is easily accessible and freely available online, and it does not require any training or previous knowledge of ASD to complete. The ATEC questionnaire is reliable; the Pearson split-half coefficient reliability test on over 1,300 completed ATEC questionnaires revealed a high score of 94 [12]. The validity of the ATEC was reviewed in August 2018, and its efficacy was found to be high [13]. The main goal of the ATEC is to assess the clinical improvement of ASD patients during a particular treatment or intervention. However, recently, there have been multiple published studies that utilized the ATEC score to assess the severity of ASD symptoms [14-16]. The higher the ATEC score, the greater the degree of impairment the patient has from the ASD symptoms. Other than the ATEC, the parental data were gathered using a separate form of multiple questions, one of which was asking if there was a diagnosis of depression during pregnancy or not.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS) version 22 (IBM Corp., Armonk, NY, USA) was used for data analysis. Categorical variables are presented as frequencies and percentages, whereas numerical variables are presented as the mean±standard deviation (SD). A linear regression model was used to test the relationship between the dependent variable ATEC and the other independent variables. Statistical significance was set at P<0.05.
Results
Patient characteristics
Initially, 369 children diagnosed with ASD according to the DSM-5 criteria and their parents were asked to complete the ATEC questionnaire. Only 77 parents completed the questionnaire, with a response rate of 20%. All included children were <18 years old. In total, 77 (100%) patients had an autistic disorder. Only two patients had siblings with ASD, and only one patient had a sibling with chronic disease (Table 1).
Table 1. Demographics of children with ASD and their parents.
ASD: autism spectrum disorder
| Number | % | ||
| Child gender | Male | 71 | 92.2 |
| Female | 6 | 7.8 | |
| Diagnosis | Autistic disorder | 64 | 83.1 |
| Unknown diagnosis | 13 | 16.9 | |
| Sibling with chronic disease | No | 76 | 98.7 |
| Yes | 1 | 1.3 | |
| Sibling with an autism diagnosis | No | 74 | 97.4 |
| Yes | 2 | 2.6 | |
| Mother’s nationality | Non-Saudi | 4 | 5.2 |
| Saudi | 73 | 94.8 | |
| Father’s nationality | Non-Saudi | 1 | 1.3 |
| Saudi | 76 | 98.7 | |
| Parents related | No | 45 | 58.4 |
| Yes | 32 | 41.6 | |
| Maternal body mass index groups | Non-obese | 63 | 81.8 |
| Obese | 14 | 18.2 | |
| Paternal body mass index groups | Non-obese | 51 | 66.2 |
| Obese | 26 | 33.8 | |
| Psychiatry illnesses in parents | No | 76 | 98.7 |
| Yes | 1 | 1.3 | |
| Chronic diseases in parents | No | 63 | 81.8 |
| Yes | 14 | 18.2 | |
| Allergies in parents | No | 60 | 77.9 |
| Yes | 17 | 22.1 | |
| Parents smoke | No | 44 | 57.1 |
| Yes | 33 | 42.9 | |
| Drug use during pregnancy | No | 51 | 66.2 |
| Yes | 26 | 33.8 | |
| Maternal depression diagnosis during pregnancy | No | 73 | 94.8 |
| Yes | 4 | 5.2 | |
| Maternal smoking during pregnancy | No | 77 | 100 |
| Yes | 0 | 0 | |
| Age at pregnancy | ≤25 | 27 | 35.1 |
| 26-30 | 24 | 31.2 | |
| ≥31 | 26 | 33.8 | |
| Number of siblings | 0 or 1 | 16 | 22.2 |
| 2 | 13 | 18.1 | |
| 3 | 18 | 25. | |
| 4 | 11 | 15.3 | |
| ≥5 | 14 | 19.4 |
Parent characteristics
Data on parents’ characteristics were obtained through self-administered questionnaires, as mentioned in the Materials & Methods section. Most parents were Saudis, 32 (41.6%) of whom were consanguineous. The prevalence of pregestation underweight, overweight, and obese mothers was 5.2%, 35.1%, and 18.2%, respectively. Further, the prevalence of pregestation underweight, overweight, and obese fathers was 0%, 28.6%, and 33.8%, respectively. Only one parent had a history of psychiatric illness, and 14 (18.2%) had a history of chronic disease. None of the mothers reported active smoking during pregnancy. Four (5.2%) mothers experienced depression during pregnancy. The age of 35.1%, 31.2%, and 33.8% of mothers during pregnancy was ≤25, 26-30, and ≥31 years, respectively, with an average age of 28.5 years. Most parents had three (25%) to four (15.3%) siblings (mean: 3.2 siblings) (Table 1). Children of consanguineous parents, underweight mothers and obese fathers, mothers with a history of depression during pregnancy, and mothers aged ≥31 years during pregnancy tended to have a higher mean ATEC score, but there was no significant difference, except maternal depression during pregnancy (P=0.0286) (Table 2).
Table 2. Mean and SD of the ATEC with each parental characteristic.
SD: standard deviation, ATEC: Autism Treatment Evaluation Checklist
| ATEC | |||
| Mean | SD | ||
| Parents related | No | 85.73 | 30.27 |
| Yes | 86.97 | 25.17 | |
| Maternal body mass index groups | Non-obese | 86.14 | 28.41 |
| Obese | 86.71 | 27.96 | |
| Paternal body mass index groups | Non-obese | 83.64 | 27.84 |
| Obese | 91.35 | 29.23 | |
| Chronic diseases in parents | No | 87.17 | 28.24 |
| Yes | 82.07 | 28.06 | |
| Allergies in parents | No | 88.65 | 27.77 |
| Yes | 77.76 | 28.4 | |
| Parents’ smoking status | No | 85.66 | 29.72 |
| Yes | 87.03 | 26.19 | |
| Drug use during pregnancy | No | 85.31 | 29.55 |
| Yes | 88.08 | 25.45 | |
| Maternal depression diagnosis during pregnancy | No | 84.62 | 27.93 |
| Yes | 116 | 4.9 | |
| Age at pregnancy | ≤25 | 87.56 | 33.38 |
| 26-30 | 82.63 | 22.49 | |
| ≥31 | 88.23 | 27.51 | |
| Number of siblings | 0 or 1 | 83.06 | 25.09 |
| 2 | 87.46 | 28.95 | |
| 3 | 81.39 | 37.4 | |
| 4 | 98.36 | 20.08 | |
| ≥5 | 84.07 | 24.96 |
Correlation between ATEC scores and autism severity
The mean ATEC score was 86.2±28.1 (SD) (range: 12-173). The mean of each domain score is shown in Figure 1. The health domain was the most significantly correlated with the ATEC score, followed by the communication, social, and sensory domains (Table 3).
Table 3. Pearson correlation between each domain of the ATEC.
*Correlation is significant at the 0.05 level (two-tailed).
**Correlation is significant at the 0.01 level (two-tailed).
ATEC: Autism Treatment Evaluation Checklist
| Communication | Social | Sensory | Health | ATEC | |
| Communication | 1 | ||||
| Social | 0.178 | 1 | |||
| Sensory | 0.540** | 0.019 | 1 | ||
| Health | 0.340** | 0.457** | 0.283* | 1 | |
| ATEC | 0.631** | 0.610** | 0.570** | 0.880** | 1 |
Figure 1. Mean score with the SD of each domain in the ATEC.
The mean±SD score of each domain of the ATEC is presented as a percentage.
SD: standard deviation, ATEC: Autism Treatment Evaluation Checklist
In linear regression analysis, consanguinity, parental chronic disease, parental allergy, smoking, drug use during pregnancy, paternal and maternal BMI, and sibling number were not significantly correlated with ATEC scores (P=0.701, 0.693, 0.133, 0.874, 0.982, 0.255, 0.778, and 0.502, respectively). However, a history of depression during pregnancy was significantly correlated with ATEC scores (P=0.055) (Table 4).
Table 4. Linear regression between dependent variables (ATEC) and other independent variables.
ATEC: Autism Treatment Evaluation Checklist
| Dependent variable (ATEC) | Intercept | P-value | B | 95% confidence interval for B | |
| Lower bound | Upper bound | ||||
| Parents related | No | 0.701 | -3.0 | -18.3 | 12.4 |
| Yes | 0.0 | ||||
| Chronic diseases in parents | No | 0.693 | 3.7 | -14.8 | 22.1 |
| Yes (reference) | 0.0 | ||||
| Allergies in parents | No | 0.133 | 13.3 | -4.2 | 30.7 |
| Yes (reference) | 0.0 | ||||
| Parental smoking | No | 0.874 | 1.2 | -14.4 | 16.9 |
| Yes (reference) | 0.0 | ||||
| Drug use during pregnancy | No | 0.982 | 0.2 | -17.8 | 18.2 |
| Yes (reference) | 0.0 | ||||
| Maternal depression diagnosis during pregnancy | No | 0.055 | -35.5 | -71.8 | 0.8 |
| Yes (reference) | 0.0 | ||||
| Age at pregnancy | ≤25 | 0.658 | -4.5 | -24.9 | 15.8 |
| 26-30 | 0.948 | -0.6 | -20.2 | 18.9 | |
| ≥31 | 0.0 | ||||
| Maternal body mass index groups | Non-obese | 0.778 | 2.8 | -16.7 | 22.3 |
| Obese (reference) | 0.0 | ||||
| Paternal body mass index groups | Non-obese | 0.255 | -9.7 | -26.6 | 7.2 |
| Obese (reference) | 0.0 | ||||
| Number of siblings | ≤2 | 0.502 | -6.2 | -24.4 | 12.1 |
| >3 (reference) | 0.0 | ||||
Discussion
Globally, it is estimated that one in every 160 individuals is diagnosed with ASD. However, in the United States, the rate is estimated to be one in 44 individuals, indicating even higher rates when individuals are well monitored [2,3,17]. Although the exact etiology of ASD is unclear, many factors, including genetics, neuroanatomical abnormalities, prenatal and perinatal factors, parental factors, and environmental factors, have been implicated in the development of ASD [4]. It is unclear whether these factors alone can explain the dramatic increase in the prevalence of ASD [5]. In this study, we explored the association between specific parental factors and ASD severity using the ATEC. To the best of our knowledge, only a few studies have utilized the ATEC scale as an effective tool to assess autism severity [14-16]. However, studies have used the ATEC to assess the response to a particular intervention or treatment.
Owing to the inconsistent findings, the association between parental comorbidities and the risk of ASD in offspring has not been well established. Krakowiak et al. explored whether diabetes, hypertension, and obesity are associated with ASD and developmental delay. They found a higher proportion of diabetes, hypertension, and obesity in mothers of children with ASD, but only obesity showed a significant correlation [18]. Reynolds et al. reported similar results in preterm children [19]. Surén et al. found a significant association between paternal, but not maternal, obesity and the risk of ASD [10]. Li et al. and Sanchez et al. found an association between maternal obesity and the risk of ASD [9,20]. In the present study, parental BMI and chronic disease were not significantly associated with ATEC scores. Because of the small sample size, we decided to only perform linear regression analysis with the ATEC as a whole (Table 3) and not with each domain (communication, social, sensory, and health). This may explain the insignificance of our results. Krakowiak et al. reported significantly worse Mullen Scales of Early Learning and Vineland Adaptive Behavior Scale scores among children with ASD born to mothers with diabetes [18]. This may highlight a possible association between parental obesity and specific chronic diseases, such as diabetes, and impairment in specific functional domains in the population with autism.
Untreated maternal depression during pregnancy has been linked to many deleterious consequences, including low birth weight, preterm labor, and postnatal cognitive and emotional complications, in addition to neuroendocrine and brain function problems [11-13]. Approximately 13% of pregnant women use antidepressants [21]. However, several studies have reported inconsistent findings regarding the association between antidepressant use during pregnancy and the risk of ASD in offspring [21-23]. Boukhris et al. found a significant association between selective serotonin reuptake inhibitor (SSRI) use during the second and third trimesters and the risk of ASD [24]. Moreover, Hagberg et al. have reported that, regardless of antidepressant use, maternal depression increases the risk of ASD [21]. This could be explained by the fact that patients with depression have a higher brain serotonin turnover than healthy individuals [25]. In contrast, Brown et al. found no association between SSRI and serotonin-norepinephrine reuptake inhibitor use and the risk of ASD [26]. Further, Sujan et al. found no significant association between antidepressant use in the first trimester and the risk of ASD [27]. However, Harrington et al. found the opposite results [28]. In our study, we found a significant correlation between a history of depression during pregnancy and ATEC scores (P=0.055). According to our linear regression analysis, having a history of depression during pregnancy would increase the ATEC score by 35.5. Further, higher scores generally indicate more severe ASD or greater functional impairment. Although the P-value is considered borderline, based on our results, we can argue that maternal depression during pregnancy is associated with more severe autism. Further analysis is needed to specify which domain of the ATEC is the most impaired by maternal depression.
Advanced parental age is a risk factor for ASD in offspring. Croen et al. reported a significant association between paternal and maternal age and the risk of ASD in offspring [29]. Additionally, Reynolds et al. concluded that the risk of autism was 5.75% higher in children of parents aged >50 years than in those of parents aged <30 years [19]. However, Reichenberg et al. found an association only between the risk of autism and paternal age [30]. Two meta-analyses on this topic have shown an association between advanced parental age and ASD in offspring [31,32]. This association can be possibly attributed to the mutation of transcription factors, which play a dominant role in gene expression. Furthermore, de novo mutations in male germ cells due to advanced age may be implicated in autism [33]. In our study, we did not find a significant association between age at pregnancy and ATEC scores, which can probably be attributed to the small sample size.
This study has several limitations. First, the study design was descriptive and cross-sectional. Moreover, given that the ATEC is a subjective tool for the assessment of function in the population with autism, it is not highly accurate as parents may overestimate or underestimate their children’s behaviors. Furthermore, some variables included were general or broad. For example, we included chronic diseases in parents and siblings and psychiatric illness in siblings, without specifying the disease itself. Another limitation is that we performed linear regression analysis with the ATEC as a whole and not with each domain (communication, social, sensory, and health). However, we believe that the ATEC is a useful tool to assess autism severity. A multicenter study with a large number of patients focusing on the effect of parental and patient factors on each domain of the ATEC is needed to better guide rehabilitation programs to clarify which domain they should focus on.
Conclusions
Our patients had a mean ATEC score of 86.2. The health domain was the most significantly correlated with ATEC scores, with a Pearson correlation of 0.880. In linear regression analysis, consanguinity, parental chronic disease, parental allergy, smoking, drug use during pregnancy, paternal and maternal BMI, and sibling number were not significantly correlated with ATEC scores (P=0.701, 0.693, 0.133, 0.874, 0.982, 0.255, 0.778, and 0.502, respectively). However, maternal depression during pregnancy was significantly correlated with ATEC scores (P=0.055).
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.Autism in context 1: classification, counting and causes. Williams K, Woolfenden S, Roberts J, Rodger S, Bartak L, Prior M. J Paediatr Child Health. 2014;50:335–340. doi: 10.1111/jpc.12451. [DOI] [PubMed] [Google Scholar]
- 2.Autism in Saudi Arabia: presentation, clinical correlates and comorbidity. Al-Salehi SM, Al-Hifthy EH, Ghaziuddin M. Transcult Psychiatry. 2009;46:340–347. doi: 10.1177/1363461509105823. [DOI] [PubMed] [Google Scholar]
- 3.Brief report: comorbid psychiatric disorders of autistic disorder. Tsai LY. J Autism Dev Disord. 1996;26:159–163. doi: 10.1007/BF02172004. [DOI] [PubMed] [Google Scholar]
- 4.Psychopathology in children and adolescents with autism compared to young people with intellectual disability. Brereton AV, Tonge BJ, Einfeld SL. J Autism Dev Disord. 2006;36:863–870. doi: 10.1007/s10803-006-0125-y. [DOI] [PubMed] [Google Scholar]
- 5.Oppositional defiant disorder as a clinical phenotype in children with autism spectrum disorder. Gadow KD, Devincent CJ, Drabick DA. J Autism Dev Disord. 2008;38:1302–1310. doi: 10.1007/s10803-007-0516-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.A meta-analysis of sensory modulation symptoms in individuals with autism spectrum disorders. Ben-Sasson A, Hen L, Fluss R, Cermak SA, Engel-Yeger B, Gal E. J Autism Dev Disord. 2009;39:1–11. doi: 10.1007/s10803-008-0593-3. [DOI] [PubMed] [Google Scholar]
- 7.Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. JAMA. 2018;319:1723–1725. doi: 10.1001/jama.2018.3060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Centers for Disease Control and Prevention. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2020. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2020. [Google Scholar]
- 9.Association between maternal obesity and autism spectrum disorder in offspring: a meta-analysis. Li YM, Ou JJ, Liu L, Zhang D, Zhao JP, Tang SY. J Autism Dev Disord. 2016;46:95–102. doi: 10.1007/s10803-015-2549-8. [DOI] [PubMed] [Google Scholar]
- 10.Parental obesity and risk of autism spectrum disorder. Surén P, Gunnes N, Roth C, et al. Pediatrics. 2014;133:0–38. doi: 10.1542/peds.2013-3664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Rimland B, Edelson SM. CA, USA: Autism Research Institute; 1999. Autism Treatment Evaluation checklist (ATEC) [Google Scholar]
- 12.Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Lonsdale D, Shamberger RJ, Audhya T. https://europepmc.org/article/med/12195231. Neuro Endocrinol Lett. 2002;23:303–308. [PubMed] [Google Scholar]
- 13.Efficacy of neurofeedback for children in the autism spectrum: a pilot study. Jarusiewicz B. J Neurotherapy. 2002;6:39–49. [Google Scholar]
- 14.Cross-cultural adaptation, reliability, and validity of the autism treatment evaluation checklist in Persian. Memari AH, Shayestehfar M, Mirfazeli FS, Rashidi T, Ghanouni P, Hafizi S. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684470/pdf/IJPD-23-269.pdf. Iran J Pediatr. 2013;23:269–275. [PMC free article] [PubMed] [Google Scholar]
- 15.Is the Autism Treatment Evaluation Checklist a useful tool for monitoring progress in children with autism spectrum disorders? Magiati I, Moss J, Yates R, Charman T, Howlin P. J Intellect Disabil Res. 2011;55:302–312. doi: 10.1111/j.1365-2788.2010.01359.x. [DOI] [PubMed] [Google Scholar]
- 16.The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. Adams JB, Baral M, Geis E, et al. J Toxicol. 2009;2009:532640. doi: 10.1155/2009/532640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Prevalence and characteristics of autism spectrum disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018. Maenner MJ, Shaw KA, Bakian AV, et al. https://doi.org/10.15585/mmwr.ss7011a1. MMWR Surveill Summ. 2021;70:1–16. doi: 10.15585/mmwr.ss7011a1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Krakowiak P, Walker CK, Bremer AA, Baker AS, Ozonoff S, Hansen RL, Hertz-Picciotto I. Pediatrics. 2012;129:0–8. doi: 10.1542/peds.2011-2583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Maternal obesity and increased risk for autism and developmental delay among very preterm infants. Reynolds LC, Inder TE, Neil JJ, Pineda RG, Rogers CE. J Perinatol. 2014;34:688–692. doi: 10.1038/jp.2014.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis. Sanchez CE, Barry C, Sabhlok A, Russell K, Majors A, Kollins SH, Fuemmeler BF. Obes Rev. 2018;19:464–484. doi: 10.1111/obr.12643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Hagberg KW, Robijn AL, Jick S. Clin Epidemiol. 2018;10:1599–1612. doi: 10.2147/CLEP.S180618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Depression during pregnancy and postpartum. Becker M, Weinberger T, Chandy A, Schmukler S. Curr Psychiatry Rep. 2016;18:32. doi: 10.1007/s11920-016-0664-7. [DOI] [PubMed] [Google Scholar]
- 23.Psychological science on pregnancy: stress processes, biopsychosocial models, and emerging research issues. Dunkel Schetter C. Annu Rev Psychol. 2011;62:531–558. doi: 10.1146/annurev.psych.031809.130727. [DOI] [PubMed] [Google Scholar]
- 24.Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. Boukhris T, Sheehy O, Mottron L, Bérard A. JAMA Pediatr. 2016;170:117–124. doi: 10.1001/jamapediatrics.2015.3356. [DOI] [PubMed] [Google Scholar]
- 25.Maternal SSRIs experience and risk of ASD in offspring: a review. Fatima Z, Zahra A, Ghouse M, Wang X, Yuan Z. Toxicol Res (Camb) 2018;7:1020–1028. doi: 10.1039/c8tx00102b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. Brown HK, Ray JG, Wilton AS, Lunsky Y, Gomes T, Vigod SN. JAMA. 2017;317:1544–1552. doi: 10.1001/jama.2017.3415. [DOI] [PubMed] [Google Scholar]
- 27.Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. Sujan AC, Rickert ME, Öberg AS, et al. JAMA. 2017;317:1553–1562. doi: 10.1001/jama.2017.3413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I. Pediatrics. 2014;133:0–8. doi: 10.1542/peds.2013-3406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Maternal and paternal age and risk of autism spectrum disorders. Croen LA, Najjar DV, Fireman B, Grether JK. Arch Pediatr Adolesc Med. 2007;161:334–340. doi: 10.1001/archpedi.161.4.334. [DOI] [PubMed] [Google Scholar]
- 30.Advancing paternal age and autism. Reichenberg A, Gross R, Weiser M, et al. Arch Gen Psychiatry. 2006;63:1026–1032. doi: 10.1001/archpsyc.63.9.1026. [DOI] [PubMed] [Google Scholar]
- 31.Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis. Sandin S, Hultman CM, Kolevzon A, Gross R, MacCabe JH, Reichenberg A. J Am Acad Child Adolesc Psychiatry. 2012;51:477–486. doi: 10.1016/j.jaac.2012.02.018. [DOI] [PubMed] [Google Scholar]
- 32.Advanced parental age and autism risk in children: a systematic review and meta-analysis. Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Acta Psychiatr Scand. 2017;135:29–41. doi: 10.1111/acps.12666. [DOI] [PubMed] [Google Scholar]
- 33.Effects of increased paternal age on sperm quality, reproductive outcome and associated epigenetic risks to offspring. Sharma R, Agarwal A, Rohra VK, Assidi M, Abu-Elmagd M, Turki RF. Reprod Biol Endocrinol. 2015;13:35. doi: 10.1186/s12958-015-0028-x. [DOI] [PMC free article] [PubMed] [Google Scholar]